منابع مشابه
Biochemical Markers of Myocardial Damage
Heart diseases, especially coronary artery diseases (CAD), are the leading causes of morbidity and mortality in developed countries. Effective therapy is available to ensure patient survival and to prevent long term sequelae after an acute ischemic event caused by CAD, but appropriate therapy requires rapid and accurate diagnosis. Research into the pathology of CAD have demonstrated the usefuln...
متن کاملBiochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?
M odern medical practice requires rapid decisions. Patients must be triaged faster, treated more expeditiously, and discharged earlier. Diagnostic tests used to evaluate patients with possible myocardial ischemia/infarction must be simple to perform and must rapidly and accurately accomplish several goals: (1) Differentiate patients with and without acute myocardial infarction (AMI). Only a sma...
متن کاملBiochemical markers of myocardial remodelling in hypertensive heart disease.
The intricate mechanisms responsible for the structural remodelling of the myocardium that facilitates the evolution to heart failure in hypertensive patients, namely in those with left ventricular hypertrophy, requires from clinicians the utilization of a multibiomarker approach for short-term and long-term stratification as well as prognostication of patients. Biochemical markers may also hel...
متن کاملBiochemical Markers of Brain Injury: An Integrated Proteomics-Based Approach
1. Ronald L. Hayes. An integrated platform for discovery and preclinical/clinical validation of biomarkers of brain injury. CHI Biomarker Validation meeting, San Francisco, Feb. 2005. 2. Linda Papa, Jose Pineda, Steve Lewis, Kevin Wang, Jason Demery, Shelley Heaton, Joe Tepas and Ronald Hayes. Levels of alpha-II spectrin breakdown products in human CSF and outcome after severe traumatic brain i...
متن کاملBiochemical markers of cerebrovascular injury in sleep apnoea syndrome.
Sleep apnoea syndrome (SAS) is a known risk factor for vascular diseases and stroke. Structural brain damage, manifesting as an overt neurological deficit or more subtly as cognitive dysfunction, is a frequent symptom in SAS. The presence of a biochemical marker of cerebral injury would be of great benefit in SAS to screen for even small brain damage and to monitor efficiacy of therapy. Therefo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Clinical Biochemistry
سال: 2007
ISSN: 0970-1915,0974-0422
DOI: 10.1007/bf02912874